Weekly Digest – January 2026 Weekly Digest – January 2026 27 January 2026: Henlius receives an IND approval for Its PD-L1-targeting ADC HLX43 in combination with anti-PD-1 mAb Serplulimab and novel anti-EGFR mAb HLX07 Shanghai Henlius Biotech has secured regulatory […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id